GSK denies Mail on Sunday report of interest in Aurinia : vi

GlaxoSmithKline on Monday dismissed a Mail on Sunday report that said that the British pharma group could be interested in bidding for autoimmune disease drug developer Aurinia Pharmaceuticals... | November 1, 2021

Related Keywords

United Kingdom , Britain , Ludwig Burger , Kirsten Donovan , Bristol Myers Squibb Co , Bloomberg News , Glaxosmithkline Plc Stock Exchange , News , Information , Press Release , Glaxosmithkline , N , Monday , Dismissed , Mail , Sunday , Report , Hat , Aid , The , British , Dharma , Group , Would , He , Interested , Bidding , Or , Autoimmune , Disease , Drug , Developer , Urinia Gsk Gb0009252882 ,